Meta Pixel

News and Announcements

Volt Bank to set tone for a new era of banking as the first digital bank to receive licence form APRA

  • Published January 22, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Volt Bank has been granted a full banking licence from the Australian Prudential Regulation Authority (APRA).

This makes them the first digital bank to receive a full banking licence from APRA.

The company is now licensed to operate as an authorised deposit-taking institution (ADI) without restrictions.

The licence will give the company an advantage over other competitive banks.

This move from APRA will allow Volt Bank to set the tone for a new era of banking.

Steve Weston, Co-Founder and CEO of Volt Bank said the bank is focused on ‘leveraging tech and data to deliver a new kind of banking experience.’

Volt Bank will use technology such as smartphone facial recognition to on board clients.

 

About Volt Bank

A confluence of factors makes now the right time to establish a digital bank in Australia. Consumer behaviour has changed from banking in branches to mobiles. In May 2018, APRA granted its first Restricted Authorised Deposit-Taking Institution (RADI) licence to volt bank limited. volt bank expects to achieve its full ADI licence by the end of 2018. volt bank will act more like a “technology company with a banking licence”, transforming the way banking is done. volt will focus on the customer with a holistic approach helping them solve their most difficult financial challenges.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now